16 December 2020 - Deborah Wilkes
Premium
Australia’s Therapeutic Goods Administration (TGA) has now given the final go-ahead for certain low-dose cannabidiol (CBD) medicines to be sold without a prescription. However, the TGA has made a number of changes to its interim decision released in September 2020.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.